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Abstract A 57 kDa protein (p57) was obtained during the study 
on phosphatidylinositol-specific phospholipase C. Its cDNA was 
isolated from calf spleen and human leukemia cell line HL60 
libraries and cloned. In the primary structures of p57, they have 
two unique amino acid sequence motifs, a WD repeat and a 
leucine zipper motif. Furthermore, p57 shared sequence similarity 
(40%) with coronin, an actin-binding protein responsible for 
chemotaxis, cell motility, and cytokinesis of Dictyostelium discoi- 
deum, which has only the WD repeat, p57 also showed an actin- 
binding activity and was mainly expressed in immune tissues. 
From these results, we conclude that p57 is a coronin-like novel 
actin-binding protein in mammalian cells but may also have a 
different function from coronin. 
Key words: cDNA cloning; Actin-binding protein; WD repeat; 
Leucine zipper motif; Coronin-homologue 
1. Introduction 
We have been interested in signal transduction processes at 
various receptor systems and studying signal transduction mol- 
ecules involved in these processes, especially in processes in- 
volving those of leukocyte activation and chemotaxis. 
Phosphatidylinositol-specific phospholipase C (PI-PLC) is one 
of the key molecules in these signal transduction pathways and 
has been examined extensively [14]. At the process of studying 
the PLC with a smaller molecular mass, we obtained a protein 
with an apparent molecular mass of 57 kDa (p57) from the 
cytosol fraction of calf thymocyte. The primary structure of p57 
shared sequence similarity with coronin [5], an actin-binding 
protein responsible for chemotaxis, cell motility, and cytokine- 
sis [6] of Dictyostelium discoideum. From this result, we ex- 
pected that p57 might have an actin-binding activity. 
Many actin-binding proteins have been identified and stud- 
ied extensively [7], because the interaction of actin and actin- 
binding proteins is considered to be very important for the 
cytoskeletal function. The cytoskeleton does not only regulate 
a cell shape, motility, and cytokinesis but also provides a place 
for various signal transduction pathways. 
In the present study, cDNA of p57 was isolated and its 
sequence was determined. Sequence analysis howed that p57 
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has two unique amino acid motifs, a WD repeat and a leucine 
zipper motif, and that the protein shares ignificant similarity 
with coronin, an actin-binding protein of Dictyostelium discoi- 
deum. Therefore, an assay for actin-binding activity was also 
performed. Furthermore, its tissue distribution i  mouse was 
investigated. The results of these studies uggest that p57 is a 
novel actin-binding protein that was mainly expressed in im- 
mune tissues. 
2. Materials and methods 
2.1. Purification of p57 according to phosphoinositide hydrolysis 
activity 
All steps were performed at 4°C. According to the phosphoinositide 
hydrolysis activity, purification steps were done with DEAE Sepharose 
CL-6B, Heparin Sepharose CL-6B, Sepharose CL-6B, Mono S and 
Superose 12 column chromatography, sequentially. Sodium dodecyl 
sulfate-polyacrylamide gel lectrophoresis (SDS-PAGE) [10] of an ac- 
tive fraction from the final purification step gave a single band with 
molecular mass of 57 kDa. The phosphoinositide hydrolysis assay was 
performed as described previously [11]. 
2.2. Sequence analysis of the lysyl-C peptides of purified p57 
Purified p57 was digested with endopeptidase lysyl-C (Boehringer 
Mannheim) as described previously [11]. p57-derived lysyl-C peptides 
were microsequenced using a PSQ-1 peptide sequencer (Shimadzu, 
Kyoto, Japan). 
2.3. cDNA cloning of calf p57 
For the plaque hybridization assay of calf p57 cDNA, a cDNA probe 
was produced by PCR. The template (5'-GATCAGTGCTATGAGG- 
ACGTCCGCGTCTCCAG-3') was prepared from the results of pep- 
tide microsequencing, that was derived from a lysyl-C peptide of puri- 
fied p57. The complement primer (5'-CTGGAGA-3') was used for 
labeling. The produced probe was used for screening a 2gt 10 calf spleen 
cDNA library constructed with a cDNA synthesis kit (Pharmacia). 
Hybridization was carried out with standard procedures. Positive 
clones were subcloned in Ml3mpl8 and sequenced by a DNA se- 
quencer (ABI). 
2.4. cDNA cloning of human p57 
For the plaque hybridization assay of human p57 cDNA, a cDNA 
was produced by PCR. PCR primers (5'-ATGAGCCGGCAGGTGG- 
Y, and 5'-CTTGGCCTGGACTGTCTCCTCCAG-Y) were synthe- 
sized based on the sequence ofthe coding region of calf p57 cDNA (Fig. 
2). PCR was performed on HL60 cDNA using these primers, the prod- 
uct of which product contained the entire sequence from starting codon 
to termination codon. The produced probe was used for screening a 2gt 
10 HL60 cDNA library constructed with a TimeSaver cDNA synthesis 
kit (Pharmacia). Hybridization was carried out with standard proce- 
dures. Positive clones were subcloned in pBluescriptII sk(-) (Strat- 
agene) and sequenced with an A.L.F. DNA sequencer (Pharmacia). 
Homology alignments were done with a GeneWorks program (Intelli- 
genetics). 
2.5. Generation of polyclonal antiserum aga&st p57 
Anti-p57 antiserum was generated inrabbits immunized with BSA- 
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conjugated synthetic peptide, KRLDRLEETVQA. This peptide corre- 
sponded to residues 449~,60 of calf p57. Serum was prepared after 
three successive immunizations given in complete Freund's adjuvant 
and in incomplete Freund's adjuvant. The generated antiserum was 
termed 1440. 
2.6. Immunoblotting ojp57 in various tissues 
The tissues of Balb/c mice were homogenized in lysis buffer (10 mM 
Tris, pH 8.0, 5 mM ethyleneglycol bis-(2-aminoethylether)tetraacetic 
human p67 
calf pS7 
a. a. pS7 (ca~ 
acid (EGTA), 0.1 mM DT~ 100 ~ml  phenylmethyl-sulphonyl fluo- 
ride, and 5 ~ml  leupeptin). SDS was added to the homogenized 
samples at the final concentration f 1% and the samples were rotated 
at 4°C. A~er the centri~gation at 14,000 x g ~r  20 min at 4°C, the 
supernatants were recovered. Then, the supernatants were mixed with 
Tris-SDS-BME Seprasol (enprotech) and these mixtures were boiled 
~r  5 min. The samples (15 fig protein/lane) were suNected to SDS- 
PAGE. The Western trans~rred membrane was blocked with 10% 
FCS/Block Ace (Dainippon Seiyaku) and immunoblotted with 1440, in 
'd~TGAGCCGGCAGGTGGTCC~[CCAGCAAGTTCCGCCACGTGTTTGGAC] 148 
-~CECA~G~TGAGCCGGCAGGTGGTCC~rCCAGCAAGTTCCGCCACGTGTTTGGAC ] 141 
MSRQVV R S S K F R HV F G Q 
~ GCCGGCCAAGGC~GACCAGTGCTATG~TGTGCGCGTCTCACAG~C~GTGGCTTCTGTGCTG] 223 GCCGGCCAAGGq~GACCAGTGCTATG~TGTGCGCGTCTCACAGA~FACCTGGG~GTGGCTTCTGTGCTG j Z16 
PA K~ ~0 CY  E DV ~V SONTWD S~ F CAV 
~~ GGCCCTGAT~GT~GGCCAG~GGG~GGGGCCTTCCTG~GCTGCCC~GGGC~] 298 ~GGCCCTGATCTGTGAGGCCAG~GGGGAGGGGCCTTCCTG~GCTGCCCCTGGGC~GAJ 291 
~P K F VA L I C E A S G G G A F L V L P L G K T 
3.373 
g RV D KN V P MV C G H TA  PV  L D IAW C P H 
~ CGTCATTGCCAGTGGCTCCGAGGACTGO~TCATGGTGTGGGAGATCCC~ATGGGGGCCT~] 448 CGTCATTGCCAGTGGCTCCGAGGACTGC~GTCATGGTGTGGGAGATCCC~ATGGGGGCCTGAJ 441 
NDNV IAS  G S E DCSVMVWE IPD GG L T 
~ CTGCCCCTGCGG~GC~TC~CACCCTGGAGGGCCACACCAAGCG~TGGGCATTGTGGCCTGGCAC~'~ SZ3 CTGCCCCTGCGG~GC~TCGT~CCCTGGAGGGCCACACCAAGCGF~TGGGCATTGTGGCCTGGCA~CA j 516 
L P L R E PVVTL  E G H TKRVG IVAWH PT  
AQNV L L SAG C DNV I L VWDV GT GVA V 
666 
L Y k G SOV H POT I  Y SV  DWS RD GA L I C 
TS  C R DKRV R I I E P RK  GT I  V l E KDR P 
~F AGGG~CCCGGCCCGTGCGTGC~--~'~C~G~C~G~AGATCCTG~CCAC~GCTTCAGCCGCAI 823 pAGGG~CCCGGCCCGTGCGTGCFTE~~.~AGATCCTGACCAC~GCTTCAGCCGCA ] 816 
H E GTRPV RAV FV  S DG K I L TTG F S R M 
S E RQVA LWDT KH k E E P L S L QE  L DT  S 
~ GTGTCCTGCTGCCCTTC~TGACCCTGACAC~ACATCGTCTACCTCTGTGGCAAGGG[~ 973 GTGTCCTG~GCCCTTC~TGACCCTGACAC~ACATCGTCTACCTCTGTGGCAAGGG~F~ACAGCTC~ 966 
S GV L L P F F D P D T N IV  Y L C G K G D S S I 
~ TCCTGCACTATCTCT(T~TGTTCAGTTCCAAG~GTCCCAGC I 1648 TCCTGCACTATCTCTC~TGTTCAGTTCCAAGGAGTCCCAGC] 1~41 
RY F E IT  S EAP  F L H YL  SMF S S K E SQR 
~ TGGGCTACATGCCCAAACGTG~GGAG~GAACAAGTGTGAGAT~TCTAC~GCTGCACG 1123 TGGGCTACATGCCCAAACGTG~ GGAG~ G~CAAGTGTGAGAT CF~_~TCTAC~GCT GCA CG 1116 
GMGYMP K RG L EVN KC E IAR  FY  K L H E 
R KC E P IAMTV PRK S D L FQ E D L YPPT  
~~ TGCCCTCACGGCTGAGGAGTGGCTGGGGGGTCGG~TGCTGGGCCCCTCCTCATCTCCC I 1273 ~TGCCCTCACGGCTGAGGAGTGGCTGGGGGGTCGGGATGCTGGGCCCCTCCTCATCTCCC] 1266 
A GPDAA L TA  E EWL GG RDA G P L L I S L 
TP  E A S GAP S S D~ ~ S R L E E E M R K L QA 
~CACGGTGCAGGAG CT~CAGAAGCG~T GGA~GG ~ G~GGAGACAGTC ~GGCCAAGTAGA~C~-~CA~GC 1498 
CACGGTGCAGGAGCT~AGAAGCGCTTGGA~GG~GGAGGAGACAGTCCAGGCC~GTAGA~AE~T~- 1489 
TV Q E L QK R L DR L E E TVQA K . 
~ T&ATAAAATGGCT~ATTTTCTGGTAAA~AAAA~AAA~AA~AAAA~AA~AAA~AAAA~ 164S T~ULTJ~U~ATGGCT~ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  1575 
~GGGGGGGGGG 1657 
. . . . . . . . . . . .  1575 
Fig. 1. Nucleotide sequences of calf and human p57 and a deduced amino acid sequence of calf p57. The underlines indicate a polyadenylation signal 
sequence (AATAAA). The bold underlines indicate the lysyl-C peptides (details in section 2) derived from calf p57. 
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10% FCS and Block Ace/PBS containing 0.05% Tween-20. This mem- 
brane was washed with 0.05% Tween-20/PBS three times and was 
immunoblotted with the secondary antibody, HRP-conjugated goat 
anti-rabbit IgG. The detection was performed using the ECL system 
(Amersham). 
2.7. Expression of glutathione S-transferase ( GST)-p57 fusion protein 
The expression vector of p57 was prepared by restrictional endonu- 
clease digestion and adaptor ligation. The fragment for expression of 
human p57 was prepared by digestion of full-length cDNA of p57 with 
PmaCI and SaeI and both adaptor I and adaptor II (adaptor I; upper 
strand 5'-GATCCGAATGAGCCGGCAGGTGGTCCGCTCCAGC- 
AAGTTCCGCCAC-Y and lower strand 5'-GTGGCGGAACTTGC- 
TGGAGCGGACCACCTGCCGGCTCATTCG-3', adaptor II; upper 
strand 5'-CCAGAAGCGCTTGGACAGGCTGGAGGAGACAGT- 
CCAGGCCAAGTAGG-3' and lower strand 5'-TCGACCTACTTG- 
GCCTGGACTGTCTCCTCCAGCCTGTCCAAGCGCTTCTGGA- 
GCT-Y) were ligated with the PmaCI-SacI fragment. The ligated frag- 
ments and adaptors were subcloned into pGEX-5X-1, GST fusion 
protein expression vector (Pharmacia) digested with BamHI and Sail. 
GST fusion protein was overexpressed in bacteria. Transformed E. coli 
was cultured overnight in 100 ml medium and diluted 10-fold with fresh 
LB medium, grown for 2 h, and then induced with 0.2 mM isopro- 
pylthio-fl-D-galactoside. After 3 h the bacteria were pelleted, suspended 
in 100 ml of lysis buffer (50 mM Tris, pH 8.0, 150 mM NaC1, 1 mM 
ethylenediaminetetraacetate (EDTA), and 0.5% Nonidet P-40), and 
incubated with 0.2 mg/ml ysozyme for 20 rain on ice. The suspensions 
were then sonicated. The insoluble materials were pelleted at 10,000 x g 
for 10 min and the supernatants were incubated with 2.5 ml of glutathi- 
one-Sepharose b ads (Pharmacia) for 30 rain at 4°C. The beads were 
washed with washing buffer (50 mM Tris, pH 8.0, 100 mM NaC1, 1 mM 
EDTA, and 0.5% Nonidet P-40) three times. The bound GST fusion 
proteins were eluted with 5 mM reduced-glutathione i  50 mM Tris, 
pH 8.0. 
2.8. Co-sedimentation assay of GST-p57 fusion protein with F-actin 
A co-sedimentation assay was performed under the following condi- 
tions. Both G-actin (15 pg/reaction) (Sigma) and fusion protein, and 
fusion protein alone were incubated in F-aetin buffer (20 mM Tris, pH 
8.0, 160 mM KC1, 0.2 mM adenosine 5'-triphosphates) for 1 h at 25°C. 
After the incubation, the reaction mixtures were ultracentrifuged at
100,000 x g for 1 h at 4°C. In the following, the reaction mixture before 
ultracentrifugation is termed the total reaction mixture. The superna- 
tants, pellets and total reaction mixture were resolved by SDS-PAGE 
(4-20% gradient gel) and gels were stained with Coomassie brilliant 
blue (CBB). 
3. Results 
3.1. Purification of p57 
p57 was purified according to phosphoinositide hydrolysis 
activity. At the final step of purifications, p57 was detected in 
single-band on SDS-PAGE stained with silver (data not 
shown). But the specific activity of the p57 fraction was lower 
than that in the partially purified fraction (data not shown). 
This suggested that PLC activity in the purified fraction was 
due to a co-purified protein, and then we attempted to deter- 
mine the characteristics of p57. First, to examine the primary 
structure of this protein, the partial amino acid sequences of 
p57 were determined. From the results of lysyl-C peptide mi- 
crosequencing and homology searching, two fragments of p57 
had a weak homology with coronin (shown in Figs. l a and 2) 
[5], an actin-binding protein. And we also found that other 
peptides were homologous to coronin (Figs. la and 2). Coronin 
has been shown to be an important functional molecule in 
Dictyostelium discoideum but coronin-like actin-binding pro- 
tein has not been found in mammalian cells. Therefore, to 
examine whether p57 was a coronin-homologue in mammalian 
cells, we tried to isolate a eDNA of p57. 
hp57 
cp57 
coronin 
~ R ~  ~GQP~OQ~EOV R~SQTT~G FC~V~pK FVAL~ 50 
QP KFVAL: 
~ W , ~ A Q ~ ~ ~ R Y F  GV~ 49 50
C E~L~L GKT~RVDKNA~VC~AP~C~)~VZA~ 100 
C E~A~L~L~L GKT~V DKNV~)4VC~(TAP~C~H~ IA~ 100 
WD~I~H E ASIa( -TT SV[I~. FN~K S~H~..F~E~L VG~V 98 
1 
~ VMV~E~LP L RE~V~K~VAWHTT~ C SA 150 VHV~TLPLRE~VV~E~FKPJ~,IVAWNPT~Q~LSA 150 
i CIWG~TDSIST~LQ~W~(RK~TI S FGPV~VTS 148 
2 
G C~V IMV~GT~AAM L~L GP E V~P~T~Y~v D~S RD~G L~C~S~RV 200 
G C~NV I LVWmJGT~/AV L~L G S DV~ 1fflrF~V D~SRD~jAL~C~RV 200 
S G~ L V KT~Q~N L ~ - - E G~S~M~C E~NHN~S~4(~KA 196 
3 
~I E~KGTV~A~D RP~E ~T RPV~V~V SE G~ L ~T~RM~QVA L W 250 
~I EmKGT I~ ( ~ . B ~ p G ~ ~ V A L  W 250 
~ F D~TN S I~N~- VVC~VKN S~I~AKD - ~VI~V~I(I'~E L HIY 244 
4 
~KHL E E~L~E L~S~L~N~V~C~S~F~ITS~ 300 
KHL EE~L~ L~TS~L~.  ~p~TN~SS~ITS~ 300 
~ RA F T ~ V  V~S A~L ~1~1S~I~.~I~G ~ ~.L V D~ 294 
5 
A~F k~Lm(  E S~4GY~VNK~ Y~ L H E RRCi~M 350 
A~F L ~IY~M~K E SW~4GYV~EV N ~  H E RK~M 350 
S~f Z~,~ ~T~C F L .~"  ~TSE~ L~VTPFT~SF 344 
~M EU~P~GPOP~IL~tLZ~'p~ 40e ~ G P O A ~  G~LL  I ~ . r -  ~ 400 . . . . .  ~ ....... AGEP . . . . . . .  S ........ KTV .................. 393 
, ,0  
SRELRVNRGLDTGRK~,T.~I~.~.~,~IIEEEMRI~ATVQL~R 450 
ASAVEFKPVVQV---QEG~K-NEKELREEYEKI~KIRVAY~£S---[~FV:~K 436 
LD~TVQAK 461 
L D RI~E ~TVQAK 461 
OAKIK~--LTN 445 
Fig. 2. Alignment of deduced amino acid sequence of human p57, calf 
p57 and coronin from Dictyostelium discoideum. Upper lanes, middle 
lanes and lower lanes show the amino acid sequence of human p57, calf 
p57 and coronin, respectively. The broken lines indicate the lysyl-C 
peptides (details in section 2) derived from calf p57. Underlines how 
the WD repeats in p57 and coronin. Amino acids indicated by arrow 
heads and boxes show the leucine zipper motif in the p57 sequence. 
3.2. eDNA cloning of calf and human p57 
A pair of oligonucleotides were designed corresponding to 
the determined amino acid sequences (Fig. 1) and a cDNA 
fragment probe was prepared. With the cDNA fragment, 
1.0 × 105 independent clones of the calf spleen Agtl0 eDNA 
library were screened. Two positive clones were isolated and 
were the same cDNA length. One of them was sequenced. This 
clone encoded a full-length of calf p57 and contained 5' and 3' 
non-coding regions, an ATG starting codon, a TAG termina- 
tion codon, and a polyadenylation signal (Fig. 1). The results 
of peptide microsequencing were confirmed by the deduced 
amino acids sequence of calf p57. 
For further analysis, we identified human p57 eDNA from 
HL60 cells. For plaque hybridization, a probe was prepared 
with PCR based on N-terminal and C-terminal sequence of calf 
p57. With the prepared cDNA fragment, 9.0 x 104 independent 
clones of the HL60 Agtl0 cDNA library were screened. Of 5 
positive clones, the longest positive clone was sequenced. This 
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Fig. 3. Immunoblotting analysis of p57 with 1440. The bands of p57 are indicated with the arrow heads at the right side of lanes. In panel (a), lane 
1, 2, and 4 show the calf thymus extract, human HL60 cell extract, and mouse thymus extract, respectively. And in lane 3, 1440 against HL60 cell 
extract is immuno-absorbed with the 1440 peptide for the immunization. Panel (b) indicates the tissue-distribution f p57 in mouse. Each lane reveals 
the tissue as shown in the figure. ALN and MLN is axiallary lymph node and mesenterium lymph node, respectively. 
clone was shown to encode a full-length of human p57 and 
contained 5' and 3' non-coding regions, an ATG starting 
codon, a TAG termination codon, a polyadenylation signal, 
and a poly(A) tail (Fig. 1). The open reading frame of calf and 
human p57 encoded 461 amino acids. The primary structures 
of calf and human p57 were highly homologous to each other 
(Fig. 2). Furthermore, in the primary structure of calf and 
human p57, there were two unique amino acid sequence motifs, 
a WD repeat and a leucine zipper motif. 
3.3. Homology search 
The deduced amino acid sequences of calf and human p57 
were compared with entries in the data base. These results 
indicated that p57 has homology with coronin, an actin-binding 
protein of Dictyostelium discoideum. No homology was de- 
tected with PLCs. As shown in Fig. 2, p57 exhibited significant 
sequence identities to coronin (40%). The WD repeat was com- 
pletely conserved between p57 and coronin, but the leucine 
zipper motif was not conserved. Only p57 had the leucine zipper 
motif. 
3.4. Immunobloning analysis of tissue distribution of p57 
The 57 kDa bands were observed in the lane of 1, 3, and 5 
(Fig. 3a). And the specificity of polyclonal antiserum was tested 
with immuno-absorption experiment using the synthesized pep- 
tide, KRLDRLEETVQA. From the results of immunoblotting 
analysis against calf thymus, human HL60 cells, and mouse 
thymus with 1440, the generated polyclonal antiserum was 
proven to cross-react with calf, human, and mouse p57 (Fig. 
3a). Since 1140 cross-reacts with mouse p57, we examined the 
tissue distribution of p57 in mouse by using 1440. We expected 
that the tissue distribution of p57 might suggest us the biolog- 
ical function of p57. The p57 was clearly detected in brain, 
thymus, spleen, bone marrow, and lymph node. And the weak 
bands were detected in lung and gut. Furthermore, p57 was not 
detected in liver, kidney, stomach, and skeletal muscle. The 
bands with lower molecular masses were considered to be non- 
specific (Fig. 3b). These data shows that p57 is mainly expressed 
in immune tissues, and interestingly, also expressed in brain. 
3.5. Co-sedimentation assay with F-actin 
The GST-fused p57 was expressed in E. coli. The expressed 
fusion protein was resolved by SDS-PAGE, and indicated the 
calculated molecular mass of GST-fused p57 (about 80 kDa) 
(data not shown). The similarity between p57 and coronin sug- 
gested that p57 is a novel actin-binding protein in mammalian 
cells. Therefore, a co-sedimentation assay of the GST-fused 
human p57 with F-actin was performed. When GST was used 
in co-sedimentation assay with F-actin or without F-actin, it 
was not able to bind to F-actin (Fig. 4). On the other hand, 
GST-fused p57 was detected in the lane of with actin, but not 
in the lane of without actin (Fig. 4). These data suggest that p57 
is responsible for the actin-binding activity, and an actin-bind- 
ing protein. 
4. Discussion 
In an attempt to isolate a PLC with a smaller molecular mass 
than those of known PLCs, we purified a protein from calf 
thymus that has phosphoinositide hydrolytic activity and a 
molecular mass of 57 kDa (p57) (data not shown). At the final 
step of purifications, p57 was detected in single-band on SDS- 
PAGE stained with silver (data not shown). But the specific 
activity of the purified p57 fraction was lower than that in the 
K. Suzuki et aL /FEBS Letters 364 (1995) 283-288 287 
GST 
F-actin ~+ + + 
( kDa } ( kDa 
66.3  
42.4 -~ w~w'~ ~= '~ " actin 42.4 
30 0 - 30 .0  
• ...................... GST 
17.2 -  17.2 
GST-p57 GST-p57 
I I I 
+ + + 
( kDa'  
GST-p57 
66.3 
actin 42.4 
30.0 
GST GST 
17.2 
T S P T S P T S P 
GST-p57 
Fig. 4. Co-sedimentation assay of GST-p57 fusion protein with F-actin. T, total reaction mixture; S, ultracentrifuged supernatant; P, ultracentrifuged 
precipitate (details in section 2). Each protein is indicated with arrow heads. 
partially purified fraction (data not shown). The results uggest 
that PLC activity in the purified p57 fraction was due to a 
co-purified protein but not due to p57 itself. Then, we were 
interested in what is p57. To examine the characteristics of this 
purified protein, first we determined the primary structure of 
this protein. From the results of lysyl-C peptide microse- 
quencing and homology searching, two peptides of p57 had a 
weak homology with coronin (shown in Figs. la and 2) [5], an 
actin-binding protein responsible for chemotaxis, cell motility, 
and cytokinesis [6] of Dictyostelium discoideum. Furthermore, 
we found that other peptides were also homologous to coronin 
[5] (Figs. 1 and 2). From these results, we considered that p57 
was a coronin-like novel actin-binding protein in mammalian. 
Then, we isolated cDNA clones of calf and human p57 (Fig. 
1). The isolated cDNA of human p57 contained an open read- 
ing frame of 461 amino acids that had revealed a striking sim- 
ilarity (95%) to bovine p57. The WD repeat and leucine zipper 
motif are completely conserved in human and bovine p57 (Fig. 
2). The expressed p57 in COS cells did not show significant PLC 
activity (data not shown). 
p57 may have a role in signal transduction because its pri- 
mary structure has two unique amino acid sequence motifs that 
are characteristic of signal transduction molecules: five WD 
repeats (Fig. 2) and a leucine zipper motif (Fig. 2) with a small 
basic region near the C terminus. The seven WD repeats have 
been found in the fl subunits of heterotrimeric guanine nucleo- 
tide binding-proteins (G-proteins) [9]. More than 20 proteins 
are known to contain the similar repeating unit and to be 
essential components of large functional protein complexes, 
such as G-proteins, PRP4, Tupl, TAFII80, p55CDC and LIS-1 
protein [10]. Though the function of the WD repeat is not yet 
clear, one possible function has been reported recently [12]. The 
fl subunit of heterotrimeric G-protein was shown to bind to the 
PH (pleckstrin homology) domain via the WD repeat. On the 
other hand, the proteins that contain a PH domain have been 
suggested to be involved in signal transduction pathways and 
in cytoskeletal function [13-16]. Based on these reports, we 
suggest hat p57 may form a protein complex with proteins 
containing a PH domain. It is assumed that such a complex 
serves ome function. Moreover, the leucine zipper motif in the 
C terminus of p57 may have a role in interacting with other 
proteins that also have a leucine zipper motif. The leucine 
zipper motif of p57, which has a small basic region, is similar 
to fra-1 (fos-related antigen-l) [17]. Most of the basic leucine 
zipper (bZIP) proteins, such as transcriptional factors, contain 
a strikingly conserved sequence [18], but p57 does not have this 
sequence. Therefore, p57 may not be a transcriptional factor 
but may be able to bind to DNA indirectly as a heterodimer 
with other transcriptional factors containing bZIP and play a 
role in transcriptional regulation. Since another known func- 
tion of the leucine zipper motif in some proteins is to participate 
in the formation of homopolymers [19], p57 may have a similar 
function. Another possible role of p57, in view of its two inter- 
esting motifs that suggest he formation of a large protein 
complex, is in intracellular signal transduction. 
Although p57 was homologous (40% identical residues) to 
coronin, an actin-binding protein of Dictyostelium discoideum 
[5] that has been associated with chemotaxis, cell motility and 
cytokinesis [6] (Fig. 2), coronin does not have a leucine zipper 
motif [6]. The long or-helical structure that is a predicted second- 
ary structure in C-terminal was conserved between coronin and 
p57. It has been discussed that the actin-binding activity of 
coronin is responsible for this s-helical structure [5]. The simi- 
larity between p57 and coronin suggests that p57 is a novel 
actin-binding protein in mammalian cells. Therefore, a co-sed- 
imentation assay of GST-fused human p57 with F-actin was 
performed. As shown in Fig. 4, GST-fused human p57 co- 
precipitated with F-actin but GST did not. This result shows 
that although the conserved actin-binding motifs are not found 
in the primary structure of p57 (Figs. 1 and 2), this protein is 
an actin-binding protein. Furthermore, the tissue-distribution 
of p57 is very interesting, p57 was clearly expressed in immune 
tissues and brain but was weakly detected in lung and gut, that 
contain alveolar macrophages and mesenterium lymph node, 
respectively (Fig. 3). Although the mechanism of neuronal mi- 
gration is not yet known, the cells that are included in the 
immune tissues are considered to be included in the chemotaxis. 
And the neuronal cells require the activity of the cell migration 
288 K. Suzuki et al./FEBS Letters 364 (1995) 283-288 
(chemotaxis-like) and the neuronal extension. The similarities 
in the primary structure, actin-binding activity, and the tissue- 
distribution of p57 suggest that p57, like coronin, may take part 
in the signal transduction pathways of chemotaxis [7]. 
In order to understand the biological functions of p57 in 
more detail, it is important to identify the proteins associated 
with p57 via the WD repeat and leucine zipper motif. The 
isolation of these binding proteins may reveal a novel signal 
transduction pathway of chemotaxis in mammalian cells. And 
we also need to investigate whether p57 has a role in cytoskel- 
etal function related to cell motility and migration. These stud- 
ies will help us to understand the mechanism of cell migration 
and chemotaxis. 
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